Skip to main content
Clinical Trials/NCT01191476
NCT01191476
Completed
Phase 4

A Prospective, Randomized, Open-label Multicenter Study Comparing the Pharmaceutical Economics and Effectiveness of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia in Laparoscopic Surgeries in China

Abbott4 sites in 1 country336 target enrollmentNovember 2010

Overview

Phase
Phase 4
Intervention
Sevoflurane Inhalational Induction and Maintenance
Conditions
Elective Laparoscopic Surgery
Sponsor
Abbott
Enrollment
336
Locations
4
Primary Endpoint
Cost of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoflurane, Total Intravenous Anesthesia (TIVA) With Propofol, or Intravenous Induction With Propofol and Inhalational Maintenance With Sevoflurane
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This study is being performed to compare the cost of anesthetic techniques with sevoflurane (low fresh gas flow balanced anesthesia) versus propofol (target controlled infusion [TCI]) versus propofol induction and sevoflurane maintenance anesthesia in subjects undergoing elective laparoscopic surgery with predicted anesthesic use between 1 and 3 hour duration.

Detailed Description

Three hundred thirty-six subjects were enrolled in this study. Two subjects, one treated with propofol for induction and maintenance and one treated with propofol for induction and sevoflurane for maintenance are not included in the study participation since no information was available for these two subjects.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
May 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Abbott
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Sevoflurane

Subjects received sevoflurane, a inhalational (volatile) anesthetic, which was administered for induction and maintenance of general anesthesia. Inhalational induction was induced via vital capacity induction at 8% and maintained at 0.8-1.5 minimum alveolar concentration (MAC).

Intervention: Sevoflurane Inhalational Induction and Maintenance

Propofol

Subjects received propofol, an intravenous (IV) anesthetic, which was administered for induction and maintenance of general anesthesia.

Intervention: Propofol Target Controlled Infusion for Induction and Maintenance

Propofol Induction and Sevoflurane Maintenance

Subjects received a bolus dose of propofol of 1.5 mg/kg administered for IV induction followed by sevoflurane at 0.8-1.5 MAC for maintenance anesthesia.

Intervention: Propofol Target Controlled Infusion for Induction and Sevoflurane Inhalation for Maintenance

Outcomes

Primary Outcomes

Cost of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoflurane, Total Intravenous Anesthesia (TIVA) With Propofol, or Intravenous Induction With Propofol and Inhalational Maintenance With Sevoflurane

Time Frame: Anesthetic Duration between 1 to 3 Hours

\[Cost of VIMA = unit price of sevoflurane X used volume of sevoflurane\]; \[Cost of TIVA = unit price of propofol X total volume of propofol in the syringe\]; \[Cost of Propofol Induction and Sevoflurane Maintenance = unit price of propofol X total volume of propofol in the syringe + unit price of sevoflurane X volume of sevoflurane in the syringe\]. The total volume of propofol in the syringe was calculated, even if all the anesthetic was not used, because it could not be reused.

Secondary Outcomes

  • Time to Loss of Consciousness(Up to 10 minutes)
  • Time to Eye Opening(Every minute after anesthesia was stopped until the subjects' eyes opened)
  • Time to Extubation(Every minute after anesthesia was stopped until extubation occurred)
  • Time to Orientation(Every minute after anesthesia was stopped until orientation occurred)

Study Sites (4)

Loading locations...

Similar Trials